Grant opportunity
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
National Institutes of Health has posted Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed), a health and biomedical sciences funding opportunity listed on Grants.gov under opportunity number RFA-CA-28-001. The call is relevant to Native American tribal governments (Federally recognized); Public and State controlled institutions of higher education; City or township governments; For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; Small businesses; Special district governments; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; County governments; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Independent school districts and should be reviewed on the official listing for final eligibility, forms, attachments and submission timing.
- Funder
- National Institutes of Health
- Forecasted close date / see official listing
- Forecasted close date / see official listing
- Award
- Up to USD 150,000
- Applicant
- Native American tribal governments (Federally recognized); Public and State controlled institutions of higher education; City or township governments; For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; Small businesses; Special district governments; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; County governments; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Independent school districts
- Discipline
- Health and Biomedical Sciences
- Region
- United States
- Posted
- Jul 14, 2026
Call summary
Overview
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) is an official Grants.gov opportunity from National Institutes of Health. It appears under opportunity number RFA-CA-28-001 and is listed for applicants working in health and biomedical sciences.
Who can apply
Native American tribal governments (Federally recognized); Public and State controlled institutions of higher education; City or township governments; For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; Small businesses; Special district governments; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; County governments; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Independent school districts. Applicants should confirm all additional eligibility limits, cost-sharing rules, institutional requirements and application package instructions on the official Grants.gov page.
What it supports
- Opportunity number: RFA-CA-28-001
- Funding category: Health
- Funding instrument: Grant
Funding and duration
Up to USD 150,000
Forecasted close date / see official listing
Forecasted close date / see official listing
How to apply
Open the official Grants.gov listing, review the full notice of funding opportunity and application package, then submit through the Grants.gov route specified by the agency.
Call details
Source-based overview
National Institutes of Health has posted Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed), a health and biomedical sciences funding opportunity listed on Grants.gov under opportunity number RFA-CA-28-001. The call is relevant to Native American tribal governments (Federally recognized); Public and State controlled institutions of higher education; City or township governments; For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; Small businesses; Special district governments; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; County governments; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Independent school districts and should be reviewed on the official listing for final eligibility, forms, attachments and submission timing.
Eligibility
Native American tribal governments (Federally recognized); Public and State controlled institutions of higher education; City or township governments; For profit organizations other than small businesses; Public housing authorities/Indian housing authorities; Small businesses; Special district governments; Native American tribal organizations (other than Federally recognized tribal governments); Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education; Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education; State governments; County governments; Private institutions of higher education; Others (see text field entitled "Additional Information on Eligibility" for clarification); Independent school districts. Applicants should confirm all additional eligibility limits, cost-sharing rules, institutional requirements and application package instructions on the official Grants.gov page.
Funding and benefits
Up to USD 150,000
Themes and supported activities
Opportunity number: RFA-CA-28-001
Funding category: Health
Funding instrument: Grant
Deadline and timeline
Forecasted close date / see official listing: Forecasted close date / see official listing.
Applicants should confirm the exact deadline time, time zone, required documents, portal steps and any institutional approvals on the official call page before submitting.
How to apply
Open the official Grants.gov listing, review the full notice of funding opportunity and application package, then submit through the Grants.gov route specified by the agency.
Before applying, check eligibility rules, budgets, attachments, page limits, partner requirements, cost-share conditions and whether the opportunity uses an expression of interest, full proposal, registration or nomination stage.